TABLE 4.

Genes modulated by HCMV in the presence of cycloheximid

Gene	Nuc IDa	Fold changeb
Angelman syndrome gene, E6-AP ubiquitin protein ligase 3A (UBE3A)	AF002224	∼29.5, ∼8.1
Beta nerve growth factor	X52599	−5.4, ∼−8.4
CIG49	AF026939	17.9, 38.9
Cryptochrome 1 (photolyase-like)	D83702	−3.3, −5.7
Cyclin-dependent kinase inhibitor 1B (p27, Kip1)	AI304854	−7.6, ∼−5.8
Folate receptor 3	U08471	−3.8, ∼−3.9
GRO3 oncogene	M36821	−6.2, ∼−7.9
Homo sapiens 14A6CK DNA sequence	X72882	−33.7, ∼3.2
Histone deacetylase 7B	AB018287	−5.5, −12.3
Human mRNA for proto-oncogene protein	D14497	−4.3, ∼−8.4
Hypothetical protein FLB6421	AI133727	26.5, ∼31.9
Inhibitor of apoptosis protein 1	U45878	−3.1, −3.7
Interferon, beta	V00535	∼65.1, ∼8.1
Interferon-induced 17-kDa/15-kDa protein	M13755	8.6, 13.4
Interferon-induced 56-kDa protein	M24594	3.9, 4.7
ISG-54K gene (interferon-stimulated gene) exon 2	M14660	29.6, ∼47.1
KIAA0354 gene product	AB002352	−6, −6.4
KIAA0477 protein	AB007946	−6.8, ∼−4.3
Melanoma growth stimulatory activity (MGSA)	X54489	−3, −4.3
Mitogen-activated protein kinase kinase kinase 8	Z14138	−5.1, ∼−4.6
Novel human gene mapping to chomosome 13, similar to rat RhoGAP	AL049801	−3.7, −3.1
Protein kinase C-alpha	AF035594	∼−10.3, ∼−4.3
rel proto-oncogene	X75042	−4.4, ∼−4.4
Transforming growth factor beta-2	M19154	∼−8.3, ∼−3.5
Tyrosine kinase arg gene mRNA	M35296	−5.4, ∼−4.1

^aNuc ID, nucleotide sequence identification or sequence accession number. 

^bTwo fold change values were determined in independent experiments. A ∼ symbol in front of a fold change value indicates that the transcript was scored as absent in either the baseline or experimental sample and that the fold change was then calculated using the background noise value as the intensity for that comparison. The complete data set with difference calls can be accessed at http://www.molbio.princeton.edu/labs/shenk/browneetal2001/.